FeesSafety
Pluang+

Douglas Dynamics posts record Q3 2026 with 35% sales growth and raises 2026 guidance.

Company Fundamentals
03 Nov 2026, 01:03 WIB
GlobeNewsWire
View Source
Bullish
Douglas Dynamics posts record Q3 2026 with 35% sales growth and raises 2026 guidance.

Douglas Dynamics reported record third quarter 2026 results with net sales up 35% to $218 million and net income rising 166% to $21.2 million, driven by strong demand and operational execution. The Work Truck Attachments segment led growth with a 78% sales increase, while the Work Truck Solutions segment also posted record sales despite some commercial demand challenges. The company raised the lower end of its 2026 guidance, expecting continued momentum but noted that winter weather could impact Q4 results. Douglas Dynamics remains confident in its strategic initiatives and operational strength heading into the winter season.

Douglas Dynamics' record third quarter 2026 results provide context for industrials investors. For readers following the Industrials sector, here is Pluang's market snapshot as of Nov 03, 2026 04:41 WIB: of 135 priced US Industrials stocks tradable on Pluang, 79 rose and 55 fell today. Notable movers include JBLU (JetBlue Airways Corporation) at USD 3.16 with a 1-day change of +10.88% and Pluang order activity showing 89% Buy, ENVX (Enovix Corporation) at USD 3.21 down 8.55% with 100% Buy activity, and FRO (Frontline Plc Ordinary Shares) at USD 52.10 down 8.44% with 100% Buy activity.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
1 hour ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
3 hours ago
Marvell agrees to buy Lumentum for $11.5B in all-stock deal amid shareholder backlash

Marvell agrees to buy Lumentum for $11.5B in all-stock deal amid shareholder backlash

Marvell Technology announced an all-stock deal to acquire Lumentum Holdings valued at $11.5 billion, offering a 23.9% premium on Lumentum's share price as of October 28. Despite the premium, some Lumentum shareholders criticized the offer, calling it...

Company Fundamentals
Bearish
5 hours ago
Pepe's trading volume outpaces Shiba Inu by over 16 times despite smaller market cap on Oct 30

Pepe's trading volume outpaces Shiba Inu by over 16 times despite smaller market cap on Oct 30

On October 30, Pepe (PEPE) recorded a trading volume of $1.457 billion, which was about 16.4 times higher than Shiba Inu's (SHIB) $88.9 million. However, Shiba Inu maintained a larger market capitalization of $2.731 billion compared to Pepe's $1.916 ...

Market News
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App